Ignite Creation Date:
2024-05-05 @ 12:05 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00247039
Status:
UNKNOWN
Last Update Posted:
2013-07-08
First Post:
2005-10-31
Brief Title:
Garlic in Patients With Febrile Neutropenia
Sponsor:
Hadassah Medical Organization
Organization:
Hadassah Medical Organization
Study Overview
Official Title:
A Controlled Study to Determine The Clinical Efficacy Of Garlic Compounds In Patients With Chemotherapy Related Febrile Neutropenia
Status:
UNKNOWN
Status Verified Date:
2013-07
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To determine the clinical effects of garlic in preventing and treatment of patients with chemotherapy related febrile neutropeniaThese patients have a very high incidence of infections which are not routinely covered by the standard empiric therapy Adding a non- toxic and possibly effective therapy may reduce the risk for infections synergize the empiric antibiotic treatment and may lessen the need for broader spectrum and more severe side effects
Detailed Description:
Patients eligible are randomized to receive placebo or garlic capsules after chemotherapy course and until leukocyte recovery
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| GAR1 | OTHER_GRANT | Dunsky grant for cancer research | None |